Alpha 2.0
Login Register
» Articles » PMID: 18180545

Inorganic Arsenic in Drinking Water and Bladder Cancer: a Meta-analysis for Dose-response Assessment

Overview
Journal Int J Environ Res Public Health
Publisher MDPI
Specialties Environmental Health
Public Health
Date 2008 Jan 9
PMID 18180545
Citations 2
Authors
Huei-An Chu
Douglas Crawford-Brown
Affiliations
Soon will be listed here.
Citing Articles

Role of oestrogen receptors in bladder cancer development.

Hsu I, Vitkus S, Da J, Yeh S Nat Rev Urol. 2013; 10(6):317-26.

PMID: 23588401 DOI: 10.1038/nrurol.2013.53.

Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure.

Jo W, Ren X, Chu F, Aleshin M, Wintz H, Burlingame A Toxicol Appl Pharmacol. 2009; 241(3):294-302.

PMID: 19732783 PMC: 2784148. DOI: 10.1016/j.taap.2009.08.027.

References
1.
Chiou H, Chiou S, Hsu Y, Chou Y, Tseng C, Wei M . Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol. 2001; 153(5):411-8. DOI: 10.1093/aje/153.5.411. View
2.
Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J . Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect. 1999; 107(9):705-10. PMC: 1566462. DOI: 10.1289/ehp.99107705. View
3.
Bates M, Rey O, Biggs M, Hopenhayn C, Moore L, Kalman D . Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol. 2004; 159(4):381-9. DOI: 10.1093/aje/kwh054. View